ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $249,000 | -10.4% | 8,819 | -16.0% | 0.01% | -10.0% |
| Q2 2019 | $278,000 | +44.8% | 10,497 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $192,000 | -86.3% | 10,497 | -90.7% | 0.01% | -90.5% |
| Q4 2018 | $1,400,000 | -49.3% | 112,686 | -21.8% | 0.08% | -38.2% |
| Q3 2018 | $2,761,000 | +245.6% | 144,029 | +145.0% | 0.14% | +240.0% |
| Q2 2018 | $799,000 | +84.1% | 58,792 | -2.3% | 0.04% | +33.3% |
| Q1 2018 | $434,000 | – | 60,202 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |